Similar to This
Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business: OSAKA/TOKYO -- Japanese drugmaker Shionogi will acquire U.S.-based biopharma ...
asia.nikkei.com/business/pharmaceuticals/shionogi-to-buy-us-based-intrabio-for-2bn-to-expand-rare-disease-drug-business
Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug ...
AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England: AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England
arabnews.com/world/astrazeneca-daiichi-breast-cancer-drug-cleared-for-nhs-use-in-england-3002134
AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England
GSK touts lung cancer data from two drugs: Today's biotech news includes late-stage results for Definium's LSD treatment, AstraZeneca breast cancer ...
statnews.com/2026/09/14/biotech-news-gsk-touts-lung-cancer-data-from-two-drugs/
GSK touts lung cancer data from two drugs
AstraZeneca Breast-Cancer Pill Etcamah Misses Key Trial Goal: Etcamah was being tested in combination with Pfizer’s Ibrance as a first-line treatment for ...
wsj.com/health/pharma/astrazeneca-breast-cancer-drug-misses-goal-in-late-stage-trial-14e2ec14
AstraZeneca Breast-Cancer Pill Etcamah Misses Key Trial Goal
Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more
statnews.com/pharmalot/2026/08/28/astrazeneca-trial-failure-monstrous-conflict-of-interest/
Pharmalittle: We’re reading about an AstraZeneca trial failure ...
AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching
statnews.com/2026/08/28/biotech-news-astrazeneca-ionis-detail-surprise-failure-of-heart-disease-drug/
AstraZeneca and Ionis detail surprise failure of heart disease drug ...
New pill provides a meaningful step forward for those fighting a rare and debilitating disease
nj.com/news/2026/08/new-pill-provides-a-meaningful-step-forward-for-those-fighting-a-rare-and-debilitating-disease.html
New pill provides a meaningful step forward for those fighting a rare and ...
Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit: Today's biotech news includes Europe pulls Tavneos over trial integrity ...
statnews.com/2026/08/17/biotech-news-akeso-summit-ivonescimabs-worsening-tumor-progression-benefit/
Akeso and Summit’s lung cancer drug shows worsening tumor-progression ...
With FDA approval, Celcuity sees big future for its new breast cancer drug: Despite stock dips, the Minnesota biotech firm thinks its innovative therapy and ...
startribune.com/celcuity-fda-approval-revtorpyk-gedatolisib-breast-cancer/601870211
With FDA approval, Celcuity sees big future for its new breast cancer drug
UAE approves new oral breast cancer treatment for hormone-resistant cases: AstraZeneca’s Etcamah oral therapy is designed for advanced breast cancer patients who ...
khaleejtimes.com/lifestyle/health/uae-approves-astrazeneca-etcamah-oral-breast-cancer-treatment
UAE approves new oral breast cancer treatment for hormone-resistant cases
Gilead and Merck’s latest trial success and flop: Today's biotech news includes AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition ...
statnews.com/2026/06/09/biotech-news-gilead-and-merck-latest-trial-success-and-flop/
Gilead and Merck’s latest trial success and flop
EU and US advisers split over AstraZeneca breast cancer drug : In today's biotech news: Merck-Kelun ADC outperforms Keytruda in trial ...
statnews.com/2026/05/22/biotech-news-astrazeneca-breast-cancer-drug-mixed-eu-and-us-approval/
EU and US advisers split over AstraZeneca breast cancer drug 
Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and more
statnews.com/pharmalot/2026/05/01/obesity-drugs-excluded-from-compounding-list-astrazeneca-setback/
Pharmalittle: We’re reading about obesity drugs and a compounding list ...
AstraZeneca’s Breast-Cancer Candidate Drug Loses FDA Panel Vote: The oncologic drugs advisory committee voted against the benefit-risk profile of camizestrant
wsj.com/health/pharma/astrazenecas-breast-cancer-candidate-drug-loses-fda-panel-vote-93d74932
AstraZeneca’s Breast-Cancer Candidate Drug Loses FDA Panel Vote
FDA warns more telehealth firms about compounded GLP-1s: Today's biotech news covers Moderna to pay major settlement in Roivant patent case ...
statnews.com/2026/03/04/biotech-news-fda-warns-telehealth-about-glp-1-compounding/
FDA warns more telehealth firms about compounded GLP-1s
FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive
cnbc.com/2026/02/18/fda-chief-marty-makary-more-drugs-should-be-over-the-counter.html
FDA chief Marty Makary says 'everything should be over the counter' unless ...
Evommune reports positive mid-stage data for eczema drug: Today's biotech news includes positive mid-stage data for Evommune eczema drug ...
statnews.com/2026/02/10/biotech-news-nektar-and-evommune-eczema-study-results/
Evommune reports positive mid-stage data for eczema drug
AstraZeneca, Daiichi Sankyo's breast cancer drug gets new FDA nod: (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi ...
asia.nikkei.com/business/pharmaceuticals/astrazeneca-daiichi-sankyo-s-breast-cancer-drug-gets-new-fda-nod
AstraZeneca, Daiichi Sankyo's breast cancer drug gets new FDA nod
Breast Cancer Patients Get Early Warning of Faltering Drugs With Blood Test: A clinical trial found that women could switch drugs without waiting for scans ...
nytimes.com/2025/06/01/health/breast-cancer-blood-test-astrazeneca.html
Breast Cancer Patients Get Early Warning of Faltering Drugs With Blood ...